The question of access
On the price and safety of medicines, changing vaccination needs, AI in medicine, prevention and new research
Access to medical treatments hinges on patients' ability to obtain them. Several issues surrounding this access were highlighted in this week's Health Matters newsletter. The Supreme Court's criticism of the exorbitant pricing of essential cancer drugs was a focal point, with the court describing it as "broad daylight dacoity." This has raised concerns about the affordability and accessibility of life-saving medications.
The report also delves into the risks associated with the overuse of painkillers and antibiotics, which can lead to kidney disease. In addition to addressing these concerns, the regulatory body FSSAI has proposed a phased rollout of front-of-pack nutrition labelling and has taken a stance against analogue paneer, explaining the implications of such decisions.
Vaccination remains a critical topic, with discussions centred around missed doses, record-keeping, catch-up vaccination for adults, and the changing immunisation needs across different life stages. The importance of maintaining vaccination records and adapting to evolving immunisation requirements is underlined. As winter approaches, the focus shifts to vaccinating older adults, particularly those living in shared households, to protect both grandparents and grandchildren.
The broader theme of preparedness and pandemic readiness is also emphasised, as India reiterates the need for resilient health systems in the face of future health crises.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- The question of access thehindu.com